Viet Nam likely to produce first homegrown COVID-19 vaccines this year

Update: 10:10 | 28/04/2021
Viet Nam is hopeful it can produce its first local COVID-19 vaccine this year, with the third trial phase of trials for the NanoCovax vaccine set to be completed in late September while the COVIVAC vaccine will enter the second phase by the end of June, according to the Ministry of Health (MoH).
Viet Nam likely to produce first homegrown COVID-19 vaccines this year
Volunteers register for participation in the clinical trial of the Covivac vaccine.

The MoH also revealed that the research team for the NanoCovax vaccine at the Viet Nam Military Medical Academy is due to report the results of the second phase of clinical trials on April 26, with the results proving to be effective as expected.

During the second phase of trials, the research team has conducted clinical trials of the NanoCovax vaccine, with the newly-detected mutated strain of the SARS-CoV-2 virus including the B.1.1.7 variant from the UK, with the results also proving effective.

Moving forward, the research team is set to report to the National Council for Ethics in Biomedical Research for the final conclusion on April 27 in order to select the optimal dosage before moving onto the third phase of trials from May 5.

With regard to the third phase, human trials to test the NanoCovax vaccine will be conducted on between 10,000 and 15,000 volunteers, including foreigners. Roughly 800 people have so far registered to become volunteers at the Military Medical Academy.

Furthermore, the third phase of clinical trials is anticipated to finish by the end of September, with the country likely to produce its first locally-made COVID-19 vaccine this year.

NanoCovax represents the first Vietnamese vaccine to make it to the human clinical trial stage and is being developed and researched by Nanogen Biotechnology Joint Stock Company.

With regard to the trial progress of the COVIVAC vaccine, Asso. Prof. Dr. Vu Dinh Thiem, director of the Center for Clinical Trials of the Central Institute of Hygiene and Epidemiology, said all 120 volunteers received their first jab on April 17. Indeed, as of April 26, a total of 36 people have been given two doses of the COVIVAC vaccine.

Dr. Thiem added that 30 volunteers will continue to receive their second dose of the COVIVAC vaccine this week, with all 120 volunteers being given their second shot by May 15.

Moreover, COVIVAC is the second COVID-19 vaccine that has been researched and produced by the Institute of Vaccines and Medical Biologicals (IVAC) at the Ha Noi Medical University.

The first phase of clinical trials has been implemented at the Ha Noi Medical University, with 120 healthy volunteers aged between 18 and 59 participating in them.

Dr. Duong Huu Thai, director of the Institute of Vaccines and Medical Biologicals (IVAC), said relevant agencies have been speeding up the process of human trials of the vaccine, with the second phase beginning in June.

TIN LIÊN QUAN
Localities intensify COVID-19 prevention measures ahead of holidays
Prime Minister: Viet Nam not allowed to ease guard against COVID-19
Yen Bai reports one new COVID-19 case on April 27
Improvements to business climate slowing: VCCI report
Preparing to welcome international visitors back to Viet Nam

(Source: VOV)